Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › FDA Revises Zika Virus Screening Guidance, Recommends Pooled Testing of Blood

FDA Revises Zika Virus Screening Guidance, Recommends Pooled Testing of Blood

Jul 06, 2018
|
staff reporter

NEW YORK (GenomeWeb) – The US Food and Drug Administration said today that it has revised its recommendations for testing blood donations for the Zika virus. In a revised final guidance, the agency said that pooled testing of donations using a screening test that it has licensed is a sufficient method for complying with its testing regulations and effectively reducing the risk of Zika virus transmission.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Roche Nabs CE Mark for SARS-CoV-2 Quantitative Antibody Test

  2. FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

  3. FDA Proposes Reclassification of Cytomegalovirus Quantitative Tests

  4. Mount Sinai Coronavirus Antibody Test Gets NYSDOH Emergency Use Authorization for Quantitative Use

  5. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.